Tavitiya Sudjaritruk, MD, PhD
Department of Pediatrics, Faculty of Medicine, Chiang Mai University
4
1
1
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Natchaya Kunanitthaworn, MD
Department of Pediatrics, Faculty of Medicine, Chiang Mai University
Shared therapeutic areas:
Worked with same sponsors:
May-Lill Garly, PHD, DTM&H
Bandim Health Project
Shared therapeutic areas:
General Manager
Tanabe Pharma Corporation
Shared therapeutic areas:
Anne Fiquet, MD
SPMSD
Shared therapeutic areas:
Raman Rao, MD
Shantha Biotechnics Limited
Shared therapeutic areas:
Novartis Vaccines and Diagnostics
Novartis
Shared therapeutic areas:
Zitta B Harboe, MD, PhD
Department of Pulmonary and Infectious Diseases, Copenhagen University Hospital - North Zealand
Shared therapeutic areas:
Claus Bistrup, MD, PhD
Department of Nephrology, Odense University Hospital
Shared therapeutic areas:
Meredith L McMorrow, MD, MPH
Centers for Disease Control and Prevention
Shared therapeutic areas:
Susanne D Nielsen, MD, DMSc
Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Long-term Immunogenicity of L-HAV Vaccine Among Healthy Thai Children and Adolescents
Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV
Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and Adolescents
Maternal Immunization With Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced-dose (2 µg) Recombinant Pertussis Vaccine (TdaP2gen) and Its Effect on the Immune Response in Thai Infants up to 15-18 Months Old
All 4 trials loaded